A Study of EDP-297 in Healthy Subjects

NCT04559126 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis

Interventions

DRUG: EDP-297
DRUG: Placebo

Sponsor

Enanta Pharmaceuticals, Inc

Collaborators

[object Object]